A Study of Utility of Pre-Myectomy Coronary Angiography in Hypertrophic Cardiomyopathy

Overview

About this study

The purpose of this study is to assess patients with hypertrophic cardiomyopathy (HCM) undergoing first time sternotomy for septal myectomy without known coronary artery disease (CAD).

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Adult patients (age 20-79; age range chosen to allow ASCVD risk calculation) undergoing myectomy as first time sternotomy at Mayo Clinic Rochester for hypertrophic obstructive cardiomyopathy with pre-operative anatomic coronary definition (defined as CTA or coronary angiography)

Exclusion Criteria:

Patients without pre-operative coronary angiogram or CT coronary angiogram at the time of myectomy
Patients with prior symptoms or stress testing felt to be of high clinical probability for atherosclerotic coronary artery disease (to be determined on the basis of clinical note review)
Patients with known CAD or coronary anatomy defined >1 year preceding myectomy

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Rochester, Minn. Mayo Clinic principal investigator Jeffrey Geske, M.D.	Closed for enrollment

Mayo Clinic Location

Status

Rochester, Minn.

Mayo Clinic principal investigator

Jeffrey Geske, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Clinical Trials